Search - tctmd.com

Displaying 61 - 80 of 205

Sort: Relevancy | Date

Presentation TVT 2022

Defining My Wish-List for the Ideal CEP Device

Presenter: Giora Weisz

June 10, 2022

Presentation TVT 2022

Real-World Anatomic Correlation between CT and Invasive Arch Angiogram on Cerebral Embolic Protection Feasibility, Usage and Outcomes in TAVR

Presenter: Maheedhar Gedela

June 10, 2022

News Conference News TVT 2022

No Stroke Reduction With Embolic Protection in TAVI, Two Studies Suggest

Michael O'Riordan

June 09, 2022

Presentation TVT 2022

Cerebral Embolic Protection and Severity of Stroke Following Transcatheter Aortic Valve Replacement

Presenter: Toshiaki Isogai

June 09, 2022

Presentation TVT 2022

EFFICACY AND SAFETY OUTCOMES OF CEREBRAL EMBOLIC PROTECTION DEVICES DURING TRANSCATHETER AORTIC VALVE REPLACEMENT: AN UPDATED META-ANALYSIS

Presenter: Arpanjeet Kaur

June 08, 2022

Presentation TVT 2022

Pattern of Hospital-Level Use of Cerebral Embolic Protection for Transcatheter Aortic Valve Replacement and Association with Outcomes

Presenter: AAMER UBAID

June 08, 2022

News Daily News

Embolic Protection Snags Debris in Nearly All Lower-Risk TAVI Patients

Todd Neale

March 16, 2022

Presentation TCT 2021

TCT 51: Complete Cerebral Protection via Left Radial Approach during Transcatheter Aortic Valve Replacement – Results from the PROTEMBO C Trial

Presenter: Tobias Schmidt

November 05, 2021

Presentation TCT 2021

Cerebral Protection in TAVR: The PROTEMBO C Trial

Presenter: Tobias Schmidt

November 04, 2021

Presentation TCT 2021

LAA Closure with the Laminar Device: technology and Clinical Update

Presenter: Jason H. Rogers

November 04, 2021

World’s First Dedicated 3D Sizing LAA Exclusion Device (Paladin Medical’s Trinity System)

Presentation TCT 2021

Introducing XCLUDE Integrated Solution. World's First Dedicated LAA 3D Sizing Device and Next-Gen LAA Exclusion Device

Presenter: Flavio Airoldi

November 04, 2021

Presentation TCT 2021

Next Generation LAA Exclusion System to Reduce Stroke Risk in AF Patients (Append)

Presenter: Zachi Berger

November 04, 2021

Presentation TCT 2021

Featured Lecture: Clinical Outcomes of LAAO versus NOACS in Atrial Fibrillation in Patients with Prior Ischemic Stroke: Is There Room for Improvement in Clinical Outcomes?

Presenter: Jens Erik Nielsen-Kudsk

November 04, 2021

Presentation TCT 2021

TCT 709: Protected TAVR with self-expandable Meril MyVal THV using ProtEmbo for intra-aortic cerebral protection

Presenter: Dariusz Jagielak

November 04, 2021

News Conference News EACTS 2021

TAVI Registries Offer Outcome Clues as Low-Risk Numbers Climb

Shelley Wood

October 20, 2021

News Conference News CRT 2021

Low Mortality and Stroke Rates With BASILICA Pre-TAVI, Registry Shows

Michael O'Riordan

March 09, 2021

News Daily News

FDA Data Raise Red Flags for Suture-Based Vascular Closure Devices

Caitlin E. Cox

February 11, 2021

News Daily News

Cerebral Embolic Protection Use Low During TAVI, Not Tied to Stroke Risk

Todd Neale

January 20, 2021

News Daily News

US TAVR Cases Pass a Quarter Million, Surpassing Surgery: Key Trends

Caitlin E. Cox

November 17, 2020

Presentation TCT 2020

Cerebral Embolic Protection and TAVR Outcomes: Results from the TVT Registry

Presenter: David Cohen

October 16, 2020

Advertisement

Defining My Wish-List for the Ideal CEP Device

Real-World Anatomic Correlation between CT and Invasive Arch Angiogram on Cerebral Embolic Protection Feasibility, Usage and Outcomes in TAVR

No Stroke Reduction With Embolic Protection in TAVI, Two Studies Suggest

Cerebral Embolic Protection and Severity of Stroke Following Transcatheter Aortic Valve Replacement

EFFICACY AND SAFETY OUTCOMES OF CEREBRAL EMBOLIC PROTECTION DEVICES DURING TRANSCATHETER AORTIC VALVE REPLACEMENT: AN UPDATED META-ANALYSIS

Pattern of Hospital-Level Use of Cerebral Embolic Protection for Transcatheter Aortic Valve Replacement and Association with Outcomes

Embolic Protection Snags Debris in Nearly All Lower-Risk TAVI Patients

TCT 51: Complete Cerebral Protection via Left Radial Approach during Transcatheter Aortic Valve Replacement – Results from the PROTEMBO C Trial

Cerebral Protection in TAVR: The PROTEMBO C Trial

LAA Closure with the Laminar Device: technology and Clinical Update

Introducing XCLUDE Integrated Solution. World's First Dedicated LAA 3D Sizing Device and Next-Gen LAA Exclusion Device

Next Generation LAA Exclusion System to Reduce Stroke Risk in AF Patients (Append)

Featured Lecture: Clinical Outcomes of LAAO versus NOACS in Atrial Fibrillation in Patients with Prior Ischemic Stroke: Is There Room for Improvement in Clinical Outcomes?

TCT 709: Protected TAVR with self-expandable Meril MyVal THV using ProtEmbo for intra-aortic cerebral protection

TAVI Registries Offer Outcome Clues as Low-Risk Numbers Climb

Low Mortality and Stroke Rates With BASILICA Pre-TAVI, Registry Shows

FDA Data Raise Red Flags for Suture-Based Vascular Closure Devices

Cerebral Embolic Protection Use Low During TAVI, Not Tied to Stroke Risk

US TAVR Cases Pass a Quarter Million, Surpassing Surgery: Key Trends

Cerebral Embolic Protection and TAVR Outcomes: Results from the TVT Registry

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content